News

Clinical Trials Arena2h
AstraZeneca’s Truqap fails in another Phase III trial
The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.
Clinical Trials Arena3h
Cullinan Therapeutics to begin US trial of CLN-978 to treat Sjögren’s disease
Biopharmaceutical company Cullinan Therapeutics is due to begin a trial of its drug candidate CLN-978 for treating Sjögren’s ...
Clinical Trials Arena3h
US FDA approves BlackfinBio’s gene therapy trial for hereditary spastic paraplegia
The US FDA has cleared BlackfinBio's application for a Phase I/II trial of BFB-101, an AAV gene therapy designed to treat ...
Clinical Trials Arena20h
Stablepharma begins first-in-human trial of “world-first” fridge-free vaccine
The World Health Organization estimates that 50% of vaccines are wasted globally each year due to cold chain issues.
Clinical Trials Arena22h
FDA confirms primary goal for Dimerix’s DMX-200 trial to treat FSGS
The US FDA has confirmed proteinuria as an acceptable primary endpoint in Dimerix ‘s Phase III ACTION3 trial of DMX-200 for ...